SCHEMBL8166240

SCHEMBL8166240

NCc1cc([N+](=O)[O-])ccc1OC(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.43
LOXL2 Q9Y4K0 1/20 0.42
AKR1C3 P42330 1/20 0.42
AKR1C2 P52895 1/20 0.42
HTT P42858 3/20 0.41
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA5A P35218 1/20 0.40
CA9 Q16790 1/20 0.40
POLB P06746 2/20 0.39
HSPB1 P04792 3/20 0.38
MEN1 O00255 3/20 0.38
MAPT P10636 3/20 0.38
KMT2A Q03164 3/20 0.38
ALDH1A1 P00352 2/20 0.38
TP53 P04637 1/20 0.38
CASP3 P42574 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3719513 0.88 AKR1C3 (0.44) TDP1LOXL2AKR1C3AKR1C2HTT
SCHEMBL4477360 0.85 AKR1C3 (0.44) TDP1AKR1C3AKR1C2HTTCA1
SCHEMBL28040904 0.83 AKR1C3 (0.44) TDP1AKR1C3AKR1C2HTTMEN1
SCHEMBL14744323 0.83 PTPRC (0.40) AKR1C3AKR1C2HSPB1MEN1MAPT
SCHEMBL8163363 0.81 NPBWR1 (0.44) TDP1AKR1C3AKR1C2HTTMEN1
SCHEMBL9367150 0.80 AKR1C3 (0.50) TDP1AKR1C3AKR1C2HTTHSPB1
SCHEMBL7681001 0.80 TDP1 (0.63) TDP1AKR1C3AKR1C2HTTHSPB1
SCHEMBL2586412 0.80 TDP1 (0.63) TDP1HTTPOLBMEN1MAPT
SCHEMBL16923592 0.78 HTT (0.62) TDP1AKR1C3AKR1C2HTTCA1
SCHEMBL30062398 0.78 HSPB1 (0.56) TDP1AKR1C3AKR1C2HTTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008079836-A2 MACROCYCLIC FACTOR VIIA INHIBITORS USEFUL AS ANTICOAGULANTS BRISTOL-MYERS SQUIBB COMPANY (US) 2008-07-03 WO disclosed